Found 71 matching trials
Mineralocorticoid Receptor in the Treatment of Severe Depression NA The proposed research aims to compare the onset of action and the efficacy ...
Show More Location
University Hospital Hamburg-Eppendorf
Learn More & Join Trial
Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure. NA Ascites is a cardinal and debilitating complication in patients with acute-...
Show More Location
Institute of Liver and Biliary Sciences
Learn More & Join Trial
Hypoglycemia and Autonomic Nervous System Function-B PHASE4 This study tests the hypothesis that, compared to prior normal blood sugar,...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants PHASE1 The purpose of this study is to investigate the safety and tolerability of ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia PHASE4 Elevated aldosterone causes moderate to severe increase in blood pressure, ...
Show More Status
Enrolling By Invitation
Location
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region
Learn More & Join Trial
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone PHASE4 The main objective of this study is to evaluate the efficacy of SZC as comp...
Show More Learn More & Join Trial
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function PHASE3 The purpose of this study is to evaluate the effectiveness of aldosterone a...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy PHASE4 Hypertrophic Cardiomyopathy (HCM) is the most common genetic cardiomyopathy...
Show More Location
Tufts Medical Center
Learn More & Join Trial
Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications NA The purpose of this study is to find out if spironolactone, a drug that blo...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA) PHASE3 Evaluation of spironolactone, a well-known cardiological treatment, in pati...
Show More Location
University Hospital, Strasbourg, France
Learn More & Join Trial